Pneumococcal conjugate second or third-dose vaccines (PCVc) in Romania
Romania: Pneumococcal conjugate second or third-dose vaccines (PCVc) was 66.0% in 2025. ◆ Volatile
Latest (2025)
66.0%
Change on year
unchanged
World rank
138th
of 194 countries
All-time high
88.0%
in 2019
All-time low
0.0%
in 2008
Years of data
18
2008–2025
Pneumococcal conjugate second or third-dose vaccines (PCVc) in Romania, 2008–2025
Source: World Health Organization, Global Health Observatory.
Analysis
In 2025, pneumococcal conjugate second or third-dose vaccines (pcvc) in Romania stood at 66.0%.
That represents a change of down 22.4% over five years.
Over the whole period, pneumococcal conjugate second or third-dose vaccines (pcvc) in Romania peaked at 88.0% in 2019 and was at its lowest, 0.0%, in 2008.
Romania ranks 138th of 194 countries on this measure, in the middle of the range.
The series is highly variable year to year, so single readings are best treated with caution.
Pneumococcal conjugate second or third-dose vaccines (PCVc) in Romania, year by year
| Year | Value | Change |
|---|---|---|
| 2008 | 0.0% | — |
| 2009 | 0.0% | — |
| 2010 | 0.0% | — |
| 2011 | 0.0% | — |
| 2012 | 0.0% | — |
| 2013 | 0.0% | — |
| 2014 | 0.0% | — |
| 2015 | 0.0% | — |
| 2016 | 0.0% | — |
| 2017 | 0.0% | — |
| 2018 | 0.0% | — |
| 2019 | 88.0% | — |
| 2020 | 85.0% | -3.4% |
| 2021 | 85.0% | +0.0% |
| 2022 | 85.0% | +0.0% |
| 2023 | 78.0% | -8.2% |
| 2024 | 66.0% | -15.4% |
| 2025 | 66.0% | +0.0% |
Romania compared with similar countries
- Romania's 66.0% is below the median for high income countries, which is 91.0%, 73% of the median. (63 countries reporting)
- Romania's 66.0% is below the median for Europe & Central Asia, which is 87.0%, 76% of the median. (51 countries reporting)
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2000s | 0.0% | 0.0% | 0.0% | 2 |
| 2010s | 8.8% | 0.0% | 88.0% | 10 |
| 2020s | 77.5% | 66.0% | 85.0% | 6 |
Countries ranked near Romania
More health data for Romania
- Un projection of annual infant deaths, annual growth rate -2.59 % change on previous year (2100)
- Heat deaths vs projected death rates, annual growth rate -0.0845 % change on previous year (2090)
- Estimated changes in temperature-related death rates compared to projected death rates 1,419 deaths per 1,000 people (2090)
- Number of infants who die before age 1 113 deaths (2100)
- Neonatal tetanus - number of reported cases, gaps filled 0 (2025)
- Population ages 00-04, female, annual growth rate -1.62 % change on previous year (2025)
- Population ages 00-04, female, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 00-04, female, per capita 0.0235 units per person (2025)
- Population ages 00-04, male, annual growth rate -1.52 % change on previous year (2025)
- Population ages 00-04, male, per unit of GDP 0 units per US$ of GDP (2025)
Frequently asked questions
- What is pneumococcal conjugate second or third-dose vaccines (pcvc) in Romania?
- Pneumococcal conjugate second or third-dose vaccines (pcvc) in Romania was 66.0% in 2025, according to World Health Organization, Global Health Observatory.
- What is the highest pneumococcal conjugate second or third-dose vaccines (pcvc) recorded in Romania?
- The highest recorded value was 88.0% in 2019.
- What is the lowest pneumococcal conjugate second or third-dose vaccines (pcvc) recorded in Romania?
- The lowest recorded value was 0.0% in 2008.
- How does Romania rank for pneumococcal conjugate second or third-dose vaccines (pcvc)?
- Romania ranks 138th out of 194 countries with data for 2025.
- Where does this Romania data come from?
- The figures come from World Health Organization, Global Health Observatory, published as part of Pneumococcal conjugate second or third-dose vaccines (PCVc) immunization coverage by the locally recommended age (%) (WUENIC). Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 18 observations, free to reuse under CC BY-NC-SA 3.0 IGO (WHO).